Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research.

Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research.

Item
http://www.wikidata.org/entity/Q47796061
Big Data: the challenge for small research groups in the era of cancer genomicsUncovering packaging features of co-regulated modules based on human protein interaction and transcriptional regulatory networksProteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.Immunoexpression analysis and prognostic value of BLCAP in breast cancerImmunohistochemistry in diagnostic surgical pathology: contributions of protein life-cycle, use of evidence-based methods and data normalization on interpretation of immunohistochemical stains.Quantitative proteomic analysis of formalin-fixed and paraffin-embedded nasopharyngeal carcinoma using iTRAQ labeling, two-dimensional liquid chromatography, and tandem mass spectrometry.Clinical infrastructures to support proteomic studies of tissue and fluids in breast cancer.Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer.DNA copy number aberrations in breast cancer by array comparative genomic hybridization.Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.Human cancer classification: a systems biology- based model integrating morphology, cancer stem cells, proteomics, and genomics.A single lysis solution for the analysis of tissue samples by different proteomic technologies.Down-regulation of the tumor suppressor protein 14-3-3sigma is a sporadic event in cancer of the breast.Comparison of proteomic and genomic analyses of the human breast cancer cell line T47D and the antiestrogen-resistant derivative T47D-r.Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype.
P2860

Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research.

Item
http://www.wikidata.org/entity/Q47796061
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Integrating proteomic and func ...... tional breast cancer research.
@en
Integrating proteomic and func ...... tional breast cancer research.
@nl
type
label
Integrating proteomic and func ...... tional breast cancer research.
@en
Integrating proteomic and func ...... tional breast cancer research.
@nl
prefLabel
Integrating proteomic and func ...... tional breast cancer research.
@en
Integrating proteomic and func ...... tional breast cancer research.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Integrating proteomic and func ...... tional breast cancer research.
@en
P2093
P2860
P304
P31
P356
10.1074/MCP.R300007-MCP200
P433
P478
P50
P577
P698